Exactech Hip Replacement Lawsuit Filed Over “Poly Wear” and “Metallosis” From Defective Liner

According to allegations raised in a product liability lawsuit filed by a Texas woman, premature wear and complications from an Exactech hip replacement resulted in the development of metal blood poisoning, known as “metallosis”, and catastrophic failure of the implant.

The complaint (PDF) was filed by Lori Morrison and her husband, Timothy, in the U.S. District Court for the Northern District of Texas on April 19, indicating that the problems were caused by a defectively designed Connexion GXL hip liner used by Exactech, Inc.

The Exactech Connexion GXL hip liner has been used with several different models of total hip replacement systems implanted since 2008, including the Exactech Novation, Exactech Acumatch and others. However, it has recently been discovered that the polyethylene liner may fail prematurely, resulting in the need for additional surgery.

In June 2021, an Exactech hip recallย was issued due to problems with Connexion GXL poly liners, which the manufacturer acknowledged is prone to deteriorate and cause a condition known as osteolysis, which destroys the surrounding bone and tissue.

"*" indicates required fields

"*" indicates required fields

Lori Morrison indicates an Exactech Connexion GXL Liner was used during her hip replacement in November 2013. However, the device had to be surgically removed in May 2020, with the surgeon determining Morrisonโ€™s implant had undergone catastrophic poly wear and due to the presence of significant metallosis, metal blood poisoning resulting in the death of tissue, throughout her hip.

โ€œPlaintiff Lori Morrison had no comorbidities or biological conditions that caused, or contributed to cause the Defective Device to fail,โ€ the Exactech hip replacement lawsuit states. โ€œThe Defective Device failed catastrophically in approximately 6 years due to significant polyethylene wear and osteolysis.โ€

The case joins a growing number of similarย hip replacement lawsuitsย being pursued over Exactech Connexion GXL liner complications, indicating that the manufacturer was aware of the high failure rates for years, but continued to sell the defective implant components to patients, in order to continue to reap massive profits.

In addition to lawsuits over the Connexion GXL liner, a growing number of Exactech knee replacement lawsuits have been filed over the past few months, since similar problems were identified with a polytehylene insert included with Exactech Optetrak, Optetrak Logic and Truliant implants distributed since 2004, which are also prone to wear out and fail prematurely

More than 140,000 implants were impacted by a separate Exactech knee recallย announced in February 2022, which

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

In a joint statement, plaintiffs and defendants in AngioDynamics port catheter lawsuits have laid guidelines for what types of cases should be selected to serve as potential bellwether trials.
Women who experienced infection, chronic inflammation, implant instability or other complications after internal bra mesh procedures are now questioning whether those risks were fully disclosed before implantation.
More than 3,300 women have filed Depo-Provera lawsuits in federal court, with several hundred more also pending in state courts in New York and Delaware, according to a recent status report.